Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000596874 | SCV000704188 | uncertain significance | not provided | 2016-12-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002438536 | SCV002744749 | uncertain significance | Cardiovascular phenotype | 2019-09-26 | criteria provided, single submitter | clinical testing | The p.V8784L variant (also known as c.26350G>C), located in coding exon 105 of the TTN gene, results from a G to C substitution at nucleotide position 26350. The valine at codon 8784 is replaced by leucine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |